Luis C. Escaf

Luis C. Escaf

Auto-generated profile, based on publicly available information

Luis C. Escaf

Clínica Oftalmológica del Caribe, Barranquilla, Colombia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
VGVirgilio Galvis
Virgilio Galvis
ATAlejandro Tello
Alejandro Tello
AOAlvaro I Ortiz
Alvaro I Ortiz
LELuis C Escaf
Luis C Escaf
Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas).

24 September 2025 in International Journal of Retina and Vitreous
Verified
Journal Article
Open access
PDF file
DSDanny Salgado-Gómez
Danny Salgado-Gómez
LELuis C. Escaf
Luis C. Escaf
OGOmaira Díaz-Granados Gonzalez
Omaira Díaz-Granados Gonzalez
JEJorge Escobar-DiazGranados
Jorge Escobar-DiazGranados
Objective: This study aims to characterize the baseline profile and clinical outcomes of pneumatic retinopexy (PR) in patients fulfilling the Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT) eligibility criteria at a tertiary referral center in Colombia. Methods: This retrospective consecutive case series included patients with primary rhegmatogenous retinal detachment (RRD) meeting PIVOT criteria between January 2021 and April 2024. The primary outcome was single-operation success (SOS) at 3 months, defined as complete retinal reattachment after one PR procedure, allowing for a supplementary gas injection within 21 days. Results: 563 newly diagnosed primary RRD cases were reported, 143 (25.4%) were PIVOT-eligible and 105 underwent PR. The SOS rate was 85.7% (90/105). Baseline age, sex, lens status, and macular status were comparable between success and failure groups. Detachment extent > 2 quadrants correlated with an increased risk of failure (p = 0.045); however, this association should be interpreted cautiously given the limited number of events. Conclusions: Approximately one-quarter of primary RRD cases at our center met PIVOT criteria. In this cohort, PR yielded a high SOS rate and remains a valuable first-line surgical option in appropriately selected patients, particularly in settings with constrained resources.